Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,772 results for "Product Liability Law & Strategy"...

Drug & Device News
November 28, 2011
Important information you need to know.
The Doctrine of Equitable Tolling and Vaccine Claims
November 28, 2011
The limitations period for the filing of claims under the "Vaccine Act" has kept many from recovering for vaccine-related injuries. Still, claimants try to stretch the boundaries, offering varying reasons for why their cases should not be time-barred.
The Use of Learned Treatises in Med Mal Litigation
November 28, 2011
Although everyone knows that medical journal articles, textbooks and practice guidelines often offer powerful ammunition for the trial lawyer, the law surrounding the so-called "learned treatise doctrine" remains neither well settled nor universally applied.
Mediation and the Medical Malpractice Case
November 28, 2011
Because mediations are becoming more frequent ' and compulsory mediation is becoming the norm in certain venues ' counsel must increase their knowledge about how to use the process to achieve the best results for their clients.
Maximizing Arbitration Provisions Post-Concepcion v. AT&T
November 23, 2011
On April 27, 2011, the United States Supreme Court issued a decision in that will have significant impacts on the prevalence of class-based claims arising out of contracts with consumers.
Practice Tip: Videos, Experts, and Other Rulings You May Have Missed
November 23, 2011
A cluster of varied, recent rulings by New York's appellate courts offers diverse lessons to practitioners. Often, the actual gleaning is not new, but a good reminder nonetheless.
The Supreme Court and Product Liability
November 23, 2011
The Supreme Court decided less than a handful of product liability cases last term. But those it did decide will have great significance in the areas of personal jurisdiction over foreign manufacturers, and federal preemption of state law.
<B><I>BREAKING NEWS:</b></i> <b>Merck Settles Vioxx Case for $950 Million</b>
November 23, 2011
Merck &amp; Co., Inc. became the latest healthcare company to strike a major settlement with the Justice Department on Nov. 22, agreeing to pay $950 million to resolve criminal and civil charges stemming from its marketing of the painkiller Vioxx.
How to Speak Accountant
November 22, 2011
This is the first in a series of articles that will help you understand your business better by discussing how accounting information is prepared, how to determine the assumptions and biases underlying the numbers, how to determine what the numbers in front of you mean, and what to do with them once you have them.
Successor Liability
November 22, 2011
An asset sale under section 363(f) of the Bankruptcy Code is becoming an increasingly popular mechanism to improve a company's financial condition as an alternative to a traditional plan of reorganization.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • A Playbook for Disrupting Traditional CRM
    Here's the playbook for disruption: Take attorneys out of the equation. Stop building CRM that succeeds or fails on their shoulders. We need to shift the focus and, instead, build the technology from the ground up for the professionals who actually use it: marketing and business development.
    Read More ›